Exploring the relationship between mental health disorders and chronic medical disease

Main Article Content

Shristi Singh
Rajkishor Yadav
Lesia Serediuk

Abstract

Background: In the recent years, global burden of chronic diseases has increased significantly, presenting a new challenge to public health systems all over the world [1]. Materials and methods: 51 patients with chronic diseases were analyzed, for whom scales (PHQ-9) and (GAD-7) were used to diagnose anxiety-depressive states. Result: Out of 51 patients n=34 patients suffered from anxiety and depression. Overall the presence of mild depression is 26.47%, moderate depression is 8.82%, moderate severe depression is 55.88% and severe depression is 8.82% and The percentage of patients suffering from minimal anxiety is 14.70%, mild anxiety is 26.47%, moderate anxiety is 23.52% and severe anxiety is 35.29%. Moderate depression was found comparatively high in patient with chronic pancreatitis (2,67%) while moderate anxiety is more prevalent in cardiovascular diseases such as heart failure (HF), coronary heart disease (CHD) in association with hypertensive diseases (HD) (2,25%). Mild depression was more common in patient with HD (23%) while mild anxiety was more common in patient with CP (2,23%). Severe depression is more common in patient with HF associated with HD (1,34%) but severe anxiety is more prevalent in patient with CHD and HD (2,17%). Moderate severe depression was found to be more prevalent in patient with HF with HD (5,26%). Conclusion. Therefore, anxiety-depressive conditions are a risk factor for chronic diseases.


Google Scholar


Article Details

How to Cite
Shristi Singh, Rajkishor Yadav, & Serediuk, L. (2024). Exploring the relationship between mental health disorders and chronic medical disease. Scientific Collection «InterConf», (188), 232–240. Retrieved from https://archive.interconf.center/index.php/conference-proceeding/article/view/5412

References

Toshtemirovna EM, Alisherovna KM, Totlibayevich YS, Xudoyberdiyevich GX. Anxiety Disorders and Coronary Heart Disease. The Peerian Journal. 2023; 11:58–63.

McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Am J Psychiatry. 2021;1;178(5):383-399.

Vaccarino V, Almuwaqqat Z, Hwan Kim J, et al. Association of Mental Stress–Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease. JAMA. 2021;326(18):1818-1828.

Deter H-C, Albert W, Validation, Orth-Gomér K, Herrmann-Lingen C, et al. Does Anxiety Affect Survival in Patients with Coronary Heart Disease?. J Clin Med. 2023;12(6): 2098.

Garcia M, Moazzami K, Almuwaqqat Z, Young A, Okoh A, Shah AJ, et al. Psychological Distress and the Risk of Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease. JACC: Advances. 2024;3(2):100794.